We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$127M
AUM Growth
+$6.18M
Cap. Flow
-$1.32M
Cap. Flow %
-1.04%
Top 10 Hldgs %
33.49%
Holding
553
New
80
Increased
86
Reduced
113
Closed
64

Top Buys

Rank Stock Value
1
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$887K
2
DFIC icon
Dimensional International Core Equity 2 ETF
DFIC
+$373K
3
AMP icon
Ameriprise Financial
AMP
+$337K
4
HUM icon
Humana
HUM
+$332K
5
ATVI
Activision Blizzard
ATVI
+$331K

Top Sells

Rank Stock Value
1
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$781K
2
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$451K
3
LH icon
Labcorp
LH
+$353K
4
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$353K
5
IAU icon
iShares Gold Trust
IAU
+$320K

Sector Composition

Rank Sector Weight
1 Technology 7.09%
2 Healthcare 4.61%
3 Industrials 3.9%
4 Financials 3.83%
5 Consumer Discretionary 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDOC icon
451
Teladoc Health
TDOC
$1.24B
$2.03K ﹤0.01%
+86
New +$2.32K
RBLX icon
452
Roblox
RBLX
$25.9B
$2.02K ﹤0.01%
71
+49
+223% +$1.72K
TWST icon
453
Twist Bioscience
TWST
$7.72B
$1.98K ﹤0.01%
83
+63
+315% +$1.83K
WRB icon
454
W.R. Berkley
WRB
$26B
$1.96K ﹤0.01%
41
– –
VERV
455
DELISTED
Verve Therapeutics
VERV
$1.95K ﹤0.01%
+101
New +$2.68K
DOC
456
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.95K ﹤0.01%
135
-8,658
-98% -$126K
PLTR icon
457
Palantir
PLTR
$420B
$1.95K ﹤0.01%
303
– –
HLNE icon
458
Hamilton Lane
HLNE
$5.78B
$1.92K ﹤0.01%
30
– –
ROKU icon
459
Roku
ROKU
$22.4B
$1.87K ﹤0.01%
+46
New +$2.4K
MNDY icon
460
monday.com
MNDY
$3.7B
$1.83K ﹤0.01%
15
-1,432
-99% -$149K
NTLA icon
461
Intellia Therapeutics
NTLA
$1.68B
$1.78K ﹤0.01%
51
+39
+325% +$1.85K
NVTA
462
DELISTED
Invitae Corporation
NVTA
$1.73K ﹤0.01%
+931
New +$2.27K
CRON
463
Cronos Group
CRON
$1.13B
$1.73K ﹤0.01%
680
-28,233
-98% -$82.8K
RJF icon
464
Raymond James Financial
RJF
$34.6B
$1.71K ﹤0.01%
16
– –
DNA icon
465
Ginkgo Bioworks
DNA
$506M
$1.7K ﹤0.01%
25
+19
+317% +$1.75K
CAMT icon
466
Camtek
CAMT
$7.67B
$1.65K ﹤0.01%
75
-5,009
-99% -$116K
CE icon
467
Celanese
CE
$4.92B
$1.64K ﹤0.01%
16
– –
SURF
468
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.46K ﹤0.01%
1,785
+1,040
+140% +$1.02K
COIN icon
469
Coinbase
COIN
$39.2B
$1.45K ﹤0.01%
+41
New +$2.16K
TSP
470
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$1.44K ﹤0.01%
875
+809
+1,226% +$2.88K
MTCH icon
471
Match Group
MTCH
$8.45B
$1.33K ﹤0.01%
32
– –
FATE icon
472
Fate Therapeutics
FATE
$319M
$1.3K ﹤0.01%
129
+99
+330% +$1.86K
EEM icon
473
iShares MSCI Emerging Markets ETF
EEM
$29.9B
$1.1K ﹤0.01%
29
– –
EWO icon
474
iShares MSCI Austria ETF
EWO
$186M
$931 ﹤0.01%
49
– –
EWZ icon
475
iShares MSCI Brazil ETF
EWZ
$8.6B
$867 ﹤0.01%
31
– –
17 18
19
20 21

Similar funds

LHCM
Lloyd Harbor Capital Management Cold Spring Harbor, New York $245M AUM 141.83% 1-Year Est. Return
JP
JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return
LC
Longitude (Cayman) Grand Cayman, Cayman Islands $244M AUM
BNMT
Bawa N Mallick Trust Forest Hills, New York $244M AUM 19.8% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return

C.M. Bidwell & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, C.M. Bidwell & Associates held 553 positions worth $127M, up 5.1% from $121M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

C.M. Bidwell & Associates's Q4 2022 filing shows 80 new, 86 increased, 113 reduced and 64 closed positions. Its largest new stake was Ameriprise Financial: 1,105 shares worth $344K. The largest sale was Vanguard Russell 2000 ETF, an estimated $781K.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 7.2% a quarter earlier, followed by Healthcare and Industrials.

  • C.M. Bidwell & Associates's largest Q4 2022 buy was Ameriprise Financial: 1,105 shares worth $344K.
  • C.M. Bidwell & Associates added most to Schwab U.S Small- Cap ETF in Q4 2022, an estimated $887K increase.
  • C.M. Bidwell & Associates's biggest Q4 2022 reduction was Vanguard Russell 2000 ETF, cutting an estimated $781K.
  • C.M. Bidwell & Associates fully exited iShares Gold Trust in Q4 2022, selling an estimated $320K.
  • C.M. Bidwell & Associates's ten largest holdings make up 33% of its $127M portfolio in Q4 2022.
  • C.M. Bidwell & Associates opened 80 new positions and closed 64 in Q4 2022.
  • C.M. Bidwell & Associates's portfolio value rose 5.1% quarter-over-quarter to $127M.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2022, filed 10 Feb 2023.